Clinical Trials Directory

Trials / Completed

CompletedNCT01038869

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Efficacy and Safety of Finacea in the Treatment of Post-Inflammatory Hyperpigmentation and Acne Vulgaris

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Derm Research, PLLC · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

Residual post-inflammatory hyperpigmentation (PIH)from acne is disturbing to individuals with skin of color. Finacea has been anecdotally known to be beneficial in resolving PIH related to acne vulgaris. However, it has not been clinically tested for this purpose. The current study will investigate the efficacy and safety of Finacea in the treatment of acne vulgaris and PIH.

Conditions

Interventions

TypeNameDescription
DRUGAzelaic acidApply sparingly to the face twice a day (morning and night). Massage gently into the skin until vanishing. Approximately 0.5g (2.5cm strip) is sufficient for the entire facial area.

Timeline

Start date
2009-12-01
Primary completion
2010-04-01
Completion
2010-05-01
First posted
2009-12-24
Last updated
2012-09-25
Results posted
2012-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01038869. Inclusion in this directory is not an endorsement.